{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T12:25:26Z","timestamp":1789647926944,"version":"4.0.0"},"reference-count":17,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2018,3,15]],"date-time":"2018-03-15T00:00:00Z","timestamp":1521072000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0006249","type":"journal-article","created":{"date-parts":[[2018,3,15]],"date-time":"2018-03-15T13:28:33Z","timestamp":1521120513000},"page":"e0006249","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":29,"title":["Rethinking the serological threshold for onchocerciasis elimination"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2084-8039","authenticated-orcid":true,"given":"Katherine M.","family":"Gass","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,3,15]]},"reference":[{"key":"ref1","first-page":"1","article-title":"Accelerating Work to Overcome the Global Impact of Neglected Tropical Diseases: A Roadmap for Implementation","year":"2012"},{"key":"ref2","unstructured":"World Health Organization: Guidelines for Stopping Mass Drug Administration and Verifying Elimination of Human Onchocerciasis. 2016."},{"key":"ref3","first-page":"334","article-title":"Elimination of Onchocercia volvulus transmission in the Santa Rosa focus of Guatemala","volume":"77","author":"KA Lindblade","year":"2007"},{"key":"ref4","first-page":"e404","article-title":"Successful interruption of transmission of Onchocerca volvulus in the Escuintla-Guatemala focus, Guatemala","volume":"3","author":"RJ Gonzalez","year":"2009"},{"key":"ref5","first-page":"339","article-title":"Serosurveillance to monitor onchocerciasis elimination: The Ugandan experience","volume":"90","author":"D Oguttu","year":"2014"},{"key":"ref6","first-page":"1603","article-title":"An immunogenic Onchocerca volvulus antigen: a specific and early marker of infection","volume":"251","author":"E Lobos","year":"1991"},{"key":"ref7","first-page":"338","article-title":"Analysis of age-dependent trends in Ov16 IgG4 seroprevalence to onchocerciasis","volume":"9","author":"A Golden","year":"2016"},{"key":"ref8","first-page":"1295","article-title":"One Hundred Years After Its Discovery in Guatemala by Rodolfo Robles, Onchocerca volvulus Transmission Has Been Eliminated from the Central Endemic Zone","volume":"93","author":"F Richards","year":"2015"},{"key":"ref9","first-page":"896","article-title":"Rapid Point-of-Contact Tool for Mapping and Integrated Surveillance of Wuchereria bancrofti and Onchocerca volvulus Infection","volume":"22","author":"C Steel","year":"2015"},{"key":"ref10","first-page":"e69231","article-title":"Extended Result Reading Window in Lateral Flow Tests Detecting Exposure to Onchocerca volvulus: A New Technology to Improve Epidemiological Surveillance Tools","volume":"8","author":"A Golden","year":"2013"},{"key":"ref11","first-page":"98","article-title":"Immunoglobulin G subclass responses of children during infection with Onchocerca volvulus","volume":"3","author":"AA Gbakima","year":"1996"},{"key":"ref12","article-title":"Transmission Assessment Surveys (TAS) to Define Endpoints for Lymphatic Filariasis Mass Drug Administration: A Multicenter Evaluation","volume":"7","author":"BK Chu","year":"2013"},{"key":"ref13","first-page":"66","article-title":"Progress towards onchocerciasis elimination in the participating countries of the African Programme for Onchocerciasis Control: epidemiological evaluation results","volume":"5","author":"AH Tekle","year":"2016"},{"key":"ref14","first-page":"e0005314","article-title":"Modelling Anti-Ov16 IgG4 Antibody Prevalence as an Indicator for Evaluation and Decision Making in Onchocerciasis Elimination Programmes","volume":"11","author":"YL Lont","year":"2017"},{"key":"ref15","first-page":"e0005097","article-title":"Costs of Transmission Assessment Surveys to Provide Evidence for the Elimination of Lymphatic Filariasis","volume":"11","author":"MA Brady","year":"2017"},{"key":"ref16","first-page":"2","article-title":"Final report of the Conference on the eradicability of Onchocerciasis","volume":"2","author":"Y Dadzie","year":"2003"},{"key":"ref17","first-page":"552","article-title":"Required duration of mass ivermectin treatment for onchocerciasis elimination in Africa: a comparative modelling analysis","volume":"8","author":"WA Stolk","year":"2015"}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0006249","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T21:37:31Z","timestamp":1540244251000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0006249"}},"subtitle":[],"editor":[{"given":"Mar\u00eda-Gloria","family":"Bas\u00e1\u00f1ez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,3,15]]},"references-count":17,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,3,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0006249","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,15]]}}}